This Phase 3 company is seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, and shares are moving up.

Late-stage theranostic company Spectral...

To read the full story on AllPennyStocks.com, click here.

Spectral Medical (TSX:EDT)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Spectral Medical.
Spectral Medical (TSX:EDT)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Spectral Medical.